Long‐Term Outcomes of LAAO Versus DOACs in Nonvalvular Atrial Fibrillation: A Meta‐Analysis of Randomized Trials
Pacing and Clinical Electrophysiology · 2026-08-13
DOI: 10.1111/pace.70395 ↗At a glance
Journal article in Pacing and Clinical Electrophysiology, published online on 2026-08-13. Written by Chidubem Ezenna and 9 co-authors. Institution: Department of Medicine, University of Massachusetts - Baystate Medical Center, Springfield, Massachusetts, USA. 14 references.
Abstract (original language)
Background
Percutaneous left atrial appendage occlusion (LAAO) is an alternative strategy for stroke prevention in patients with nonvalvular atrial fibrillation (AF) with contraindications to long‐term oral anticoagulation therapy. However, evidence comparing the long‐term outcomes of LAAO with those of direct oral anticoagulants (DOAC) remains limited.
Methods
A systematic search was conducted across PubMed, Scopus, and the Cochrane databases through April 2026. Co‐primary outcomes were major adverse cardiovascular and cerebrovascular events (MACCE; composite of cardiac death, stroke, or systemic embolism) and net adverse clinical events (NACE; composite of MACCE and non‐procedure‐related bleeding). Secondary endpoints included individual components of co‐primary endpoints, ischemic and hemorrhagic stroke, all‐cause death, major or clinically significant bleeding (procedure + non‐procedure related), and stroke or systemic embolism. The random‐effects model was used to generate risk ratios (RRs) and 95% CIs.
Results
Four randomized controlled trials comprising 5890 AF patients and a median follow‐up of 3 years were included. There was no significant difference between LAAO and DOAC therapy in the risk of MACCE (RR 1.17; 95%CI 0.96–1.41; I 2 = 0%) or NACE (RR 0.89; 95%CI 0.65–1.24; I 2 = 85%). Both LAAO and DOAC therapy were similar in risk of cardiac death, stroke, systemic embolism, hemorrhagic stroke, ischemic stroke, all‐cause mortality, stroke or systemic embolism, and pericardial effusion. LAAO was associated with a lower risk of non‐procedure‐related bleeding (RR 0.60; 95%CI 0.47–0.76; I 2 = 59%).
Conclusion
LAAO demonstrated efficacy comparable to DOAC therapy in reducing the risk of MACCE, NACE, and ischemic events, while significantly reducing the risk of non‐procedure‐related bleeding. Our findings support a tailored approach to stroke prevention in AF, wherein LAAO serves as an effective alternative for patients with contraindications to DOAC therapy.
Subjects
Author keywords
Authors and institutions
- Department of Medicine, University of Massachusetts - Baystate Medical Center, Springfield, Massachusetts, USA.
- Department of Cardiovascular Medicine, Baystate Medical Center and Division of Cardiovascular Medicine, University of Massachusetts-Baystate, Springfield, Massachusetts, USA.
- Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, Arizona, USA.
- Department of Medicine, Medical College Thiruvananthapuram, Thiruvananthapuram, Kerala, India.
- Department of Medicine, Mount Auburn Hospital-Havard Medical School, Cambridge, Massachusetts, USA.
- Department of Radiology, 37 Military Hospital, Accra, Ghana.
ORCID profiles: Chidubem Ezenna, Khalid Sawalha, Sammudeen Ibrahim, Mrinal Murali Krishna, Meghna Joseph, Lakshmi Sai Niharika Janga, Abdul-Daaim Mohammed-Murtala, Raiza Rossi, Andrew M Goldsweig
Cite
APA
Ezenna, C., Sawalha, K., Ibrahim, S., Krishna, M. M., Joseph, M., Janga, L. S. N., Nadeem, S., Mohammed-Murtala, A. D., Rossi, R., & Goldsweig, A. M. (2026). Long‐Term Outcomes of LAAO Versus DOACs in Nonvalvular Atrial Fibrillation: A Meta‐Analysis of Randomized Trials. Pacing and Clinical Electrophysiology. https://doi.org/10.1111/pace.70395
Vancouver
Ezenna C, Sawalha K, Ibrahim S, Krishna MM, Joseph M, Janga LSN, et al. Long‐Term Outcomes of LAAO Versus DOACs in Nonvalvular Atrial Fibrillation: A Meta‐Analysis of Randomized Trials. Pacing and Clinical Electrophysiology. 2026. doi:10.1111/pace.70395
BibTeX
@article{Ezenna2026,
author = {Ezenna, Chidubem and Sawalha, Khalid and Ibrahim, Sammudeen and Krishna, Mrinal Murali and Joseph, Meghna and Janga, Lakshmi Sai Niharika and Nadeem, Samia and Mohammed-Murtala, Abdul-Daaim and Rossi, Raiza and Goldsweig, Andrew M},
title = {Long‐Term Outcomes of LAAO Versus DOACs in Nonvalvular Atrial Fibrillation: A Meta‐Analysis of Randomized Trials},
journal = {Pacing and Clinical Electrophysiology},
year = {2026},
doi = {10.1111/pace.70395}
}
EUVIMED